Evonik unveils bioactive sphingolipid
At NYSCC Suppliers’ Day in November, Evonik launched a bioactive sphingolipid called Sphinox Defenda (INCI: Hydroxybutyroyl Phytosphingosine (proposed)).
The company describes this as “a unique derivative of the naturally occurring phytosphingosine, offering skin defence and protection benefits”.
“Defending the skin on a cellular level, Sphinox Defenda protects the skin from UV-induced DNA damage while also fighting environmental aggressions,” Evonik said. “At the same time, the active accelerates skin regeneration and can re-balance the skin tone after summer environmental stresses. Additionally, it also reduces signs of sun-induced premature ageing.”
Sphingolipids were first isolated in the 19th century. Ceramides, the most prominent group in the family are well known to keep the skin barrier healthy and good looking. Some ceramides and sphingolipids even provide bioactive functions due to their role in regulating cell differentiation, proliferation and various metabolic pathways, it is claimed.